Biotech News

Repligen Corporation to Present at Jefferies Global Healthcare Conference

Repligen (RGEN)RepligenConference / presentation

Repligen Corporation (NASDAQ:RGEN), today announced that it will participate in the Jefferies Global Healthcare Conference in London, UK. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst-led discussion on November 18 th at 2:00 p.m. GMT.

Related news

Repligen

Bioprocessing Technology Supplier Repligen is a global life sciences company focused on technologies and systems used in biologic drug manufacturing. Its customers include biopharmaceutical developers and contract development and manufacturing organizations seeking greater efficiency, control, and scalability in production. Four Core...

Recent company news

Stock data

Close
170.29 USD
Market cap
6.83B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States